GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (OTCPK:ONTTF) » Definitions » Equity-to-Asset

Oxford Nanopore Technologies (Oxford Nanopore Technologies) Equity-to-Asset : 0.83 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Oxford Nanopore Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $815.0 Mil. Oxford Nanopore Technologies's Total Assets for the quarter that ended in Dec. 2023 was $983.6 Mil. Therefore, Oxford Nanopore Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.83.

The historical rank and industry rank for Oxford Nanopore Technologies's Equity-to-Asset or its related term are showing as below:

ONTTF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.66   Med: 0.82   Max: 0.84
Current: 0.83

During the past 6 years, the highest Equity to Asset Ratio of Oxford Nanopore Technologies was 0.84. The lowest was 0.66. And the median was 0.82.

ONTTF's Equity-to-Asset is ranked better than
71.64% of 1562 companies
in the Biotechnology industry
Industry Median: 0.67 vs ONTTF: 0.83

Oxford Nanopore Technologies Equity-to-Asset Historical Data

The historical data trend for Oxford Nanopore Technologies's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Equity-to-Asset Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.67 0.66 0.84 0.84 0.83

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.86 0.84 0.85 0.83

Competitive Comparison of Oxford Nanopore Technologies's Equity-to-Asset

For the Biotechnology subindustry, Oxford Nanopore Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Equity-to-Asset falls into.



Oxford Nanopore Technologies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Oxford Nanopore Technologies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=815.001/983.623
=0.83

Oxford Nanopore Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=815.001/983.623
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Nanopore Technologies  (OTCPK:ONTTF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Oxford Nanopore Technologies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies (Oxford Nanopore Technologies) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (Oxford Nanopore Technologies) Headlines

From GuruFocus

ONT Chosen for Comprehensive Human Genome Program

By ACCESSWIRE ACCESSWIRE 05-13-2022

Genomics England Expands Nanopore Use in Cancer

By ACCESSWIRE ACCESSWIRE 04-04-2022

Fastest Human Genome Sequence Uses Oxford Nanopore

By ACCESSWIRE ACCESSWIRE 01-13-2022

Fastest Human Genome Sequence Uses Oxford Nanopore

By ACCESSWIRE ACCESSWIRE 01-13-2022

Oxford Nanopore Announces Technology Updates

By ACCESSWIRE ACCESSWIRE 12-02-2021

ONT Shows New High-Accuracy, High-Output Chemistry

By ACCESSWIRE ACCESSWIRE 03-30-2022

Oxford Nanopore Announces Tech Updates

By ACCESSWIRE ACCESSWIRE 05-20-2022